Vireo Growth (VREOF) Change in Accured Expenses (2020 - 2025)

Vireo Growth (VREOF) reported Change in Accured Expenses of $10.1 million for Q4 2025, up 747.1% on a YoY basis from $1.2 million in Q4 2024, and up 154.18% sequentially from -$18.6 million in Q3 2025.

Vireo Growth (VREOF) Change in Accured Expenses (2020 - 2025) Analysis & Trends

Vireo Growth (VREOF) has 6 years of Change in Accured Expenses data on file, last reported at $10.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 747.1% year-over-year to $10.1 million; the trailing twelve-month figure through Dec 2025 stood at -$8.7 million (down 462.65% YoY), and the FY2025 full-year result was -$8.7 million, down 462.65% from the prior year.
  • Change in Accured Expenses climbed to $10.1 million in Q4 2025, from -$18.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $10.1 million in Q4 2025 to a low of -$18.6 million in Q3 2025.
  • A 5-year average of -$284488.8 and a median of $607847.0 in 2024 frame the typical range for Change in Accured Expenses.
  • Peak annual rise in Change in Accured Expenses reached 932.47% in 2025, while the deepest fall reached 797218.55% in 2025.
  • Tracing VREOF's Change in Accured Expenses over 5 years: stood at $5.2 million in 2021, then slumped by 160.13% to -$3.1 million in 2022, then increased by 25.38% to -$2.3 million in 2023, then soared by 150.95% to $1.2 million in 2024, then surged by 747.1% to $10.1 million in 2025.
  • Business Quant data shows VREOF's Change in Accured Expenses at $10.1 million in Q4 2025, -$18.6 million in Q3 2025, and -$2.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 89.24 Bn 87.37 Bn - -
2 Teva Pharmaceutical Industries 35.91 Bn 32.17 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.61 Bn 30.67 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.55 Bn 23.49 Bn 4.39 Bn -
5 United Therapeutics 23.28 Bn 21.13 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 20.54 Bn 20.54 Bn - -
7 Viatris 20.31 Bn 18.50 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.55 Bn 12.12 Bn 785.00 Mn -
10 Vireo Growth 10.52 Bn 10.37 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 10.08 Mn
Dec 31, 2025 10.08 Mn
Sep 30, 2025 -18.61 Mn
Sep 30, 2025 -18.61 Mn
Jun 30, 2025 -1.99 Mn
Jun 30, 2025 -1.99 Mn
Mar 31, 2025 1.80 Mn
Mar 31, 2025 1.80 Mn
Dec 31, 2024 1.19 Mn
Dec 31, 2024 1.19 Mn
Sep 30, 2024 -2,334.00
Sep 30, 2024 -2,334.00
Jun 30, 2024 1.04 Mn
Jun 30, 2024 1.04 Mn
Mar 31, 2024 174,340.00
Mar 31, 2024 174,340.00
Dec 31, 2023 -2.34 Mn
Dec 31, 2023 -2.34 Mn
Sep 30, 2023 -1.48 Mn
Sep 30, 2023 -1.48 Mn